These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia. Smith BR; Guinan EC; Parkman R; Ferrara J; Levey RH; Nathan DG; Rappeport JM Transplantation; 1985 Jun; 39(6):671-3. PubMed ID: 3890295 [No Abstract] [Full Text] [Related]
16. Possible role of lymphocyte cytotoxicity in bone-marrow grafting. Oldham RK; Simmler MC Transplant Proc; 1974 Dec; 6(4):417-9. PubMed ID: 4280166 [No Abstract] [Full Text] [Related]
17. Allogeneic marrow grafting for treatment of aplastic anemia. Storb R; Thomas ED; Buckner CD; Clift RA; Johnson FL; Fefer A; Glucksberg H; Giblett ER; Lerner KG; Neiman P Blood; 1974 Feb; 43(2):157-80. PubMed ID: 4149232 [No Abstract] [Full Text] [Related]
18. Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HL-A-identifcal unrelated donor. Speck B; Zwaan FE; van Rood JJ; Eernisse JG Transplantation; 1973 Jul; 16(1):24-8. PubMed ID: 4576852 [No Abstract] [Full Text] [Related]
19. [Indications for bone marrow transplantation in aplastic anemia and acute myeloid leukemia]. Speck B Schweiz Med Wochenschr; 1973 Apr; 103(14):508-11. PubMed ID: 4144734 [No Abstract] [Full Text] [Related]
20. Treatment of severe aplastic anaemia. Bacigalupo A Baillieres Clin Haematol; 1989 Jan; 2(1):19-35. PubMed ID: 2645962 [No Abstract] [Full Text] [Related] [Next] [New Search]